You may never have stopped to think that the coffee you’re going to drink after dinner could make you lazier the next day but, like Freakonomics, Jawbone can bring all kinds of weird correlations to the surface. Take, for example, the data that indicates that female users (and, while this could be true for men as well, Antabi specifically points to females) typically burn more calories and take more steps the day after they’ve had a good night’s sleep.
Even with drug makers’ recent increases in digital spending, the pharmaceutical industry is repeatedly said to be a laggard in terms of its speed in adoption of social media.
Among the 50 largest manufacturers worldwide, more than half still do not use it to actively engage consumers or patients. Most of them use social media as a unilateral broadcasting channel and no more than ten are on Twitter, Facebook and YouTube.
Pharmaceutical companies largely avoid involvement, cowering from regulatory wrath. They fear a loss of messaging control, privacy concerns and a lack of familiarity with community building. In addition, they struggle to quantify a return on investment.
So how do you actually know what physicians are saying about your drug? Can you identify the top ten fears of patients suffering from the conditions treated by your market leading product?
CARE and its partners are preparing to provide emergency mobile health teams to serve people affected by the violence in Gaza. Needs are particularly high for pregnant women and for those who can’t travel to hospitals or medical clinics. Pregnant women are travelling to hospitals in the midst of the bombing to get medical support, while other people are unable or unwilling to leave their houses for anything other than life-threatening injuries.
Right now in the United States there are over 40 million Americans aged 65 or older. In fact, people born between 1946 and 1964 – the “baby boomers” – make up nearly half of the population in the United States and every day 8,000 more of them turn 65.
Up until now this group has largely been ignored by most mobile technology companies, but recent announcements from Apple and Samsung show that this is no longer the case.
After attending OPEN Health's inaugural 'Health Innovation: Big Ideas' event in London, Paul Tunnah outlines some of the concepts that could be game changers for the pharma industry and the broader future of healthcare.
Eighty percent of smartphone users are interested in using their smartphones to interact with health care providers, according to a FICO survey of 2,239 adult smartphone users from the UK, Australia, Brazil, China, France, Germany, India, Italy, Japan, Korea, Mexico, Russia, Turkey, and the United States.
The survey analyzed how consumers prefer to interact with health care providers on mobile devices, online and in-person.
Among technologists, mobile health is thriving. Since the start of 2013, more than $750 million in venture capital has been invested in companies that do everything from turn your smartphone into a blood pressure gauge to snapping medical–quality images of the inner ear. Apple, Qualcomm, Microsoft, and other corporate giants are creating mobile health products and investing in startups.
Apple didn’t choose just any partner for its enterprise bid. IBM itself is no stranger to healthcare, after all, it made healthcare the flagship use case for Watson, the data intelligence processor that mimics human thinking and learning well enough that it managed to beat the best Jeopardy champions back in 2011. It’s been providing backup support for oncologists ever since. IBM knows how to manage data in a healthcare setting.
There are many methods of utilizing mHealth that are currently being tested by medical facilities and healthcare organizations around the globe. And across the board, the test results point to the positive impact mHealth solutions can provide.
Just because people are expecting Apple to revolutionize wearables with its long-awaited iWatch, doesn’t mean that there aren’t already some interesting developments going on in the wearable tech field.
I’m a massive fan of Jawbone, which has just updated its UP by Jawbone iOS app with a new fitness-oriented update – designed to focus on food-related goals, such as weight and calorie intake.
With that in mind, there’s a new weight management feature which allows you to set goals with regards to weight, and then track this progress by way of straightforward tools for logging food, weight and calorie balance.
The new Kinect, the second generation of Microsoft’s motion capture camera technology, has been making healthcare headlines for nearly a year now as a few select companies were able to tinker with prototypes. The version of the device that was connected to the Xbox One gaming console was made available back in November. But starting tomorrow, Kinect for Windows version 2 will be available commercially, complete with a software development kit (SDK) for developers.
Pixelberry Studios has partnered with the National Eating Disorders Association to create a new in-game storyline centered around eating disorders. The game will also offer educational resources to the estimated 20 million teenagers across the United States who are not happy with their bodies.
Digitally Sick are back and have taken the opportunity to look at the three big hitters for digital health in 2014: Social. HCP communications and big data (with the exception of mobile health which needs a pod of it's own).
Social media is now almost passé but over the last decade has revolutionised all aspects of pharma communications from patient support to clinical trials. In 2014 we are still struggling with how we should communicate with HCP's and finally big data, or data, is now the most exciting frontier in healthcare, what are the issues and how can this be leveraged by pharma?
The mobile health market will grow eightfold over the course of the next decade, from $5.1 billion in 2013 to $41.8 billion in 2023,according to a recent report from Lux Research. The firm defines mobile health technology as leveraging “common consumer electronics and mobile communication technologies to collect and analyze personal health data”. The decade of impressive growth will be driven by vital sign monitoring and in vitro diagnostic devices, according to the report.